{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-107736","form_type":"8-K","ticker":null,"cik":"0001429560","company_name":"TREVENA INC","filed_at":"2024-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.431870+00:00","generated_at":"2026-05-30T16:31:21.768018+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Trevena terminates CEO, COO/CFO, and CMO without cause; all continue in acting roles","bullets":["CEO Carrie Bourdow, COO/CFO Barry Shin, and CMO Mark Demitrack terminated Oct 5, 2024 as cost-cutting measure.","Bourdow remains Chairman and Acting CEO; Shin as Acting COO/CFO; Demitrack as Acting CMO.","Bourdow severance: $877,500 salary, $526,500 bonus, $321,078.69 pro rata bonus, plus health payment.","Equity vesting accelerated for 12 months of shares; additional benefits if change of control occurs.","Shin and Demitrack signed consulting agreements for continued advisory at prior compensation rates."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-107736","json":"https://secwatch.observer/filing/0001104659-24-107736.json","markdown":"https://secwatch.observer/filing/0001104659-24-107736.md","text":"https://secwatch.observer/filing/0001104659-24-107736.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1429560/000110465924107736/0001104659-24-107736-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1429560/000110465924107736/tm2425984d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T16:31:21.768018+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"05fb06632f","claim":"Barry Shin was terminated as Executive Vice President, Chief Operating Officer and Chief Financial Officer at TREVENA INC.","evidence_excerpt":"approved the termination of employment, without cause, of Carrie L. Bourdow, the Company’s President and Chief Executive Officer; Barry Shin, the Company’s Executive Vice President, Chief Operating Officer and Chief Financial Officer; and Mark A. Demitrack, MD, the Company’s Senior Vice President and Chief Medical Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1429560/000110465924107736/0001104659-24-107736-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Executive Vice President, Chief Operating Officer and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"17e3b28240","claim":"Carrie L. Bourdow was terminated as President and Chief Executive Officer at TREVENA INC.","evidence_excerpt":"approved the termination of employment, without cause, of Carrie L. Bourdow, the Company’s President and Chief Executive Officer; Barry Shin, the Company’s Executive Vice President, Chief Operating Officer and Chief Financial Officer; and Mark A. Demitrack, MD, the Company’s Senior Vice President and Chief Medical Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1429560/000110465924107736/0001104659-24-107736-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"ebbe92404d","claim":"Mark A. Demitrack was terminated as Senior Vice President and Chief Medical Officer at TREVENA INC.","evidence_excerpt":"approved the termination of employment, without cause, of Carrie L. Bourdow, the Company’s President and Chief Executive Officer; Barry Shin, the Company’s Executive Vice President, Chief Operating Officer and Chief Financial Officer; and Mark A. Demitrack, MD, the Company’s Senior Vice President and Chief Medical Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1429560/000110465924107736/0001104659-24-107736-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Senior Vice President and Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}